Incline Equity Partners, a private equity firm, completed the investment in NovaVision, a provider of neurostimulation medical devices, technologies, and solutions to noninvasively restore the vision of patients with neurological visual impairments. Financial terms were not disclosed. “NovaVision’s extensive in-house production capabilities provide a strong competitive advantage and have driven significant growth. As an established platform in the fragmented consumable security products space, there is tremendous opportunity to expand the Company’s offering through strategic acquisitions. Additionally, we plan to enhance the Company’s sales and digital marketing strategies to accelerate new customer acquisition and drive brand awareness. We look forward to our partnership with the entire NovaVision team," Evan Weinstein, Incline Partner.